FNPFX
Price
$61.16
Change
+$1.16 (+1.93%)
Updated
Apr 24 closing price
Net Assets
134.95B
MLMAX
Price
$19.85
Change
+$0.37 (+1.90%)
Updated
Apr 24 closing price
Net Assets
40.9M
Ad is loading...

FNPFX vs MLMAX

Header iconFNPFX vs MLMAX Comparison
Open Charts FNPFX vs MLMAXBanner chart's image
American Funds New Perspective F3
Price$61.16
Change+$1.16 (+1.93%)
VolumeN/A
Net Assets134.95B
Morgan Stanley Instl Global Core A
Price$19.85
Change+$0.37 (+1.90%)
VolumeN/A
Net Assets40.9M
FNPFX vs MLMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FNPFX vs. MLMAX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNPFX is a Buy and MLMAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FNPFX has more cash in the bank: 135B vs. MLMAX (40.9M). FNPFX pays higher dividends than MLMAX: FNPFX (0.90) vs MLMAX (0.00). FNPFX was incepted earlier than MLMAX: FNPFX (8 years) vs MLMAX (9 years). MLMAX (2.32) is less costly to investors than FNPFX (0.41). FNPFX is a more actively managed with annual turnover of: 24.00 vs. MLMAX (18.00). MLMAX has a lower initial minimum investment than FNPFX: MLMAX (1000) vs FNPFX (1000000). MLMAX annual gain was more profitable for investors over the last year : 5.75 vs. FNPFX (1.04). MLMAX return over 5 years is better than : 79.84 vs. FNPFX (44.22).
FNPFXMLMAXFNPFX / MLMAX
Total Expense Ratio0.411.3530%
Annual Report Gross Expense Ratio0.412.3218%
Fund Existence8 years9 years-
Gain YTD-4.879-6.03081%
Front LoadN/A5%-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets135B40.9M330,073%
Annual Yield % from dividends0.900.00-
Returns for 1 year1.045.7518%
Returns for 3 years8.5426.6032%
Returns for 5 years44.2279.8455%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BIPIX36.58N/A
N/A
ProFunds Biotechnology UltraSector Inv
FINSX38.87N/A
N/A
Fidelity Advisor New Insights I
BRUKX14.79N/A
N/A
MFS Blended Research Value Equity R2
JUSYX15.35N/A
N/A
JPMorgan US Small Company R5
MMUCX22.58N/A
N/A
MFS Utilities C